Meningococcal vaccine market Size to reach USD 5.47 Billion 2032 | Emergen Research

Increasing prevalence of meningitis and rising investment in new vaccine development are key factors driving the market revenue growth.

The global meningococcal vaccine market size was USD 3.10 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. A recent market research report highlights key drivers, insights, and segment analysis shaping the market landscape. Advancements in Multi-Component Vaccines: The market witness's significant advancements in multi-component vaccines, such as hexavalent and heptavalent options, providing wider coverage against various serogroups and driving revenue growth. Inclusion of New Technologies: New technologies like Reverse Vaccinology, Genomic Sequencing, Cell-Based Vaccine Production, and Outer Membrane Vesicle (OMV) Vaccines are enhancing quality, accelerating development processes, and contributing to market growth. Increasing Prevalence of Meningitis: The rising prevalence of meningitis, with approximately 500,000 cases reported annually according to the National Center for Biotechnology Information, underscores the importance of prevention and drives market growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2875

Rising Investment in New Vaccine Development: Investment in vaccine development, supported by global health initiatives and pandemic preparedness efforts, is a key driver of market revenue growth. Technological Advancements: Technological advancements like Conjugate Vaccine Development, Nanoparticle, and Delivery Systems are expected to further boost the market.Stringent Approval and Safety Concerns: Stringent approval processes and safety concerns pose challenges to market growth.High Development Costs: The high cost associated with vaccine development, production, and distribution acts as a restraint on market revenue growth.

Segment Insights: Meningococcal Vaccine Type Insights: The market is segmented into conjugate, polysaccharide, and others. The dominance of the conjugate segment is attributed to its improved safety profile and broader protection against various strains. Meningococcal Vaccine Serotype Insights: Serotype B accounted for the largest market share in 2022, with significant growth expected in the serotype C segment due to the emergence of more aggressive strains.

Meningococcal Vaccine Age Group Insights: Children and adults segment accounted for the largest market share in 2022, driven by widespread integration into vaccination schedules. Meningococcal Vaccine End-Use Insights: Hospitals accounted for the largest revenue share in 2022, attributed to their infrastructure and expertise in handling vaccination programs and outbreaks.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2875

Major Companies and Competitive Landscape
The global the global meningococcal vaccine market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Meningococcal vaccine solutions.

Some major players included in the global Meningococcal vaccine market report is:
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• GSK plc.
• Merck & Co., Inc.
• Walvax Biotechnology Co., Ltd.
• Incepta Pharmaceuticals Ltd
• Johnson & Johnson Private Limited
• AstraZeneca
• Bavarian Nordic

Strategic Development
• On 14 March 2023, GSK announced results from the phase III trial of its MenABCWY combination vaccine candidate. The trial aimed to prove the vaccine's safety, effectiveness, and ability to trigger immunity against serogroups A, B, C, W, and Y. The MenABCWY candidate matched the immune response of two established meningococcal vaccines, Bexsero and Menveo, for all five serogroups.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/meningococcal-vaccine-market

Meningococcal Vaccine Segment Analysis

For the purpose of this report, Emergen Research has segmented global the global meningococcal vaccine market on the basis of Vaccine Type, Age Group, Serotype, end-use, and region:
• Vaccine Type Outlook (Revenue, USD Billion; 2019-2032)
o Conjugate
o Polysaccharide
o Others
• Age Group Outlook (Revenue, USD Billion; 2019-2032)
o Infants
o Children and Adults

• Vaccine Serotype Outlook (Revenue, USD Billion; 2019-2032)
o Serotype A
o Serotype B
o Serotype C
o Serotype Y
o Serotype W-135

• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospital
o Research and Academic institute
o Others

• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of MEA

Emergen Research is Offering Exclusive Customization as per your Specific Requirements@ https://www.emergenresearch.com/request-for-customization/2875

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.